To access this element change to forms mode OFF
Grant Award View - GA89311
Optimising Q fever vaccination in Australia: Protecting our rural...
GA ID:
GA89311
Agency:
Department of Health and Aged Care
Approval Date:
25-May-2020
Publish Date:
29-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2023
Value (AUD):
$1,772,624.41
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2019_MRFF_RCRDUN_RCRDUN_2020
Grant Activity:
Optimising Q fever vaccination in Australia: Protecting our rural adolescents
Purpose:
Q fever is a serious disease and effects rural pupulations predominantly. This risk of infection is especially higher in drought conditions. There is a highly effective Q fever vaccine but it is only recommended for those 15 years and older. In this grant we will study the safety and effectiveness of Q fever vaccine in children aged 10-14 years. The goal is to widen the age recommendation for the Q fever vaccine and ultimately protect more rural adolescents.
GO ID:
GO Title:
MRFF Clinical Trials Activity - RCRDUN Initiative – 2019 Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity
Internal Reference ID:
MRF1200579
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, QLD
Postcode:
Multiple
Country:
AUSTRALIA